Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

• Status: Active, not recruiting
• Trial end date: 2022-03-31
• Target enrollment: 0
• Participant gender: Male

Summary

This is a multicenter, open-label, long-term, extension, phase 2 study to evaluate the safety and efficacy of long-term treatment with DS-5141b in patients with DMD who have completed DS5141-A-J101.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daiichi Sankyo Co., Ltd.

Criteria

Inclusion Criteria:

• Has competed a study of DS5141-A-J101

Exclusion Criteria:

• Significant safety issues in a study of DS5141-A-J101

• Patient who does not consent to use appropriate contraception

• Patient not appropriate to participant in the study as determined by the Investigator